Lung cancer screening – information for patients

The National Cancer Institute has developed a guide for patients and clinicians to review the data from the NLST to facilitate communication about the benefits and harms of screening. Summing from the table and extrapolating from the study results here are some possible talking points: – Mortality is decreased by 20% relative to cxr alone over a […]

Influenza Immunization 2015-16

 Appropriate orders  Code <65 yo: quadrivalent vaccine (multidose vial with preservative):     IMM155 65 or older: high dose trivalent (‘Flu vaccine HD 65+):                      IMM31 -EPIC will block you from ordering the high dose vaccine in patients <65 years old (even if immunosuppressed, not approved yet for this indication) –Reference article Pregnant or infants: preservative […]

ILD Research Trials

Simtuzumab trial (RAINIER, Gilead sponsored) is actively recruiting. In brief, the study is a multicenter, phase 2 randomized, double-blind, placebo-controlled trial of a subcutaneous LOXL2 monoclonal antibody in patients with Idiopathic Pulmonary Fibrosis (IPF) up to 180 weeks.   Roel will be screening clinics to look for potentially suitable candidates but would contact you to check […]